Wolfgang Miesbach Shares Newly Released Gene Therapy Qualification Criteria Paper
Wolfgang Miesbach, Professor of Medicine at Frankfurt University Hospital, shared a post on X:
“Exciting News! Our opinion paper on gene therapy qualification criteria has just been published! It outlines comprehensive standards for hub-and-spoke centers delivering gene therapy for haemophilia, helping ensure safety and efficacy across Europe and beyond:
Timely infrastructure guidance: The paper establishes practical qualification criteria for haemophilia centres delivering gene therapy, helping address new organizational, technical, and clinical requirements as gene therapies move into real-world practice.
Expert consensus: A comprehensive survey achieved 100% response among interdisciplinary specialists, ensuring robust recommendations grounded in broad clinical experience.
Hub-and-spoke model: The publication details a scalable and flexible framework—hub centres manage dosing and complexity while spoke centres provide local follow-up—making advanced therapies feasible and accessible across diverse care settings.
Unprecedented multidisciplinary team requirements including gene therapy liaison nurses, specialized pharmacists, administrative coordinators, and mandatory access to hepatologists.
Clear operational standards: The authors provide actionable criteria (e.g., bioisolator for ATMPs, 24-hour on-call service, rapid laboratory turnaround) and delineate staff roles, allowing centres to objectively assess readiness.
Flexible and adaptive: The model accommodates regional differences and supports spoke centre capacity-building, allowing responsibility to shift as local experience increases—a practical approach for evolving health systems.
Focus on safety and coordination: Emphasizes standardized protocols, scenario preparedness (“dry run” exercises), and robust SOPs for adverse event management, underpinning a safety-first transition to gene therapy.
Globally relevant: While based on European experience, the findings and framework are adaptable to international settings, with comparisons to other models such as the US health system.
Congratulations and a BIG THANK YOU to the EAHAD Gene Therapy Working Group!”
For more information follow the link.
Stay informed with Hemostasis Today.
-
Jul 22, 2025, 17:19Wolfgang Miesbach Shares Newly Released Gene Therapy Qualification Criteria Paper
-
Jul 22, 2025, 17:05EAHAD Launches Europe-Wide Survey on Haemophilia Gene Therapy Readiness
-
Jul 22, 2025, 09:26Hemophilia of Georgia Highlights Participation in WFH 2025 Summit and Global Youth Training
-
Jul 22, 2025, 08:55tPA in Action: Quick‑Guide to Alteplase Dosage for Common Thrombotic Emergencies
-
Jul 22, 2025, 08:37Georgina Santiapillai Wins 2025 BSH Crucible Prize
-
Jul 22, 2025, 09:17Decoding Antiphospholipid Syndrome: Why Triple Positivity Is a Red Flag for Thrombosis
-
Jul 21, 2025, 16:24Code I26: A Precise Tool to Strengthen VTE Surveillance
-
Jul 20, 2025, 17:12Thromboelastography: Coagulation Beyond INR and aPTT
-
Jul 20, 2025, 16:555 Crucial Insights into Low VWF QL: Uncovering a Distinct Cause of Bleeding
-
Jul 19, 2025, 17:16Promising 85% Response: Ru-D Regimen Shows Hope for Adults with HLH
-
Jul 16, 2025, 15:04Toward Hemophilia Gene Therapy for All? Insights from Prof. Flora Peyvandi in Blood Advances
-
Jul 14, 2025, 16:39Dr. Philipp Bücke: MRI Proven as No.1 Choice for Accurate TIA Diagnosis
-
Jul 13, 2025, 16:05EMA and HMA Mark a Key Step with 1st AI Observatory Report
-
Jul 13, 2025, 15:35World’s First Liver Transplant for Plasminogen Deficiency Performed at KFSHRC
-
Jul 7, 2025, 17:08Detecting Anti-Drug Antibodies to Emicizumab: A French Center’s Remarkable Experience
-
Jul 22, 2025, 16:48How Children See Blood Clots: World Thrombosis Day Shares Artwork from Young Artists
-
Jul 22, 2025, 08:48NBCA: From Marathon Dreams to ICU — Sam’s Blood Clot Wake-Up Call
-
Jul 21, 2025, 13:10What’s Slowing Down Gene Therapy Uptake in Hemophilia? Brian O’Mahony Explains the Real-World Barriers
-
Jul 20, 2025, 17:17Michael Makris Shares 2 Fascinating Lessons from Hemophilia Care in Japan
-
Jul 16, 2025, 10:24Salma Ismail: Honored to Be Invited By the EHA2025 as Part of Their Lighting the Flame Program